January 12, 2021 - CardioFocus Invited to Participate in 23^rd Annual ICR Conference and Needham Virtual Growth Conference

MARLBOROUGH, MA – January 12, 2021 - CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that Chief Executive Officer & President Burke T. Barrett will present at the 23rd Annual ICR Conference,…

January 11, 2021 - CardioFocus® Annouces Expanded Distribution Partnership with Microport™ CRM to Include Spain and Portugal

MARLBOROUGH, MA – January 11, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablationtreatment for atrial fibrillation (AFib), announced today that it has expanded its existing French distribution partnershipagreement with MicroPort CRM in France to include…

January 4, 2021 - Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments

ROME – January 4, 2021 – Angelini Pharma, an international pharmaceutical company which is a part of the private ItalianAngelini Group – and Arvelle Therapeutics, a Swiss-based biopharmaceutical company focused on bringing innovativetreatments…